Medicare may begin to cover renal denervation with Medtronic’s Symplicity device by October, which could drive coverage among ...

Medtronic (NYSE: MDT) says CMS is opening a national coverage analysis on renal denervation (RDN) procedures for patients with hypertension.

New technologies for atrial fibrillation, hypertension, diabetes and neurological conditions are poised for fast growth, ...

While deep-brain stimulation therapy has been available for people with Parkinson’s disease for decades, Medtronic has now ...

Medtronic remains a "Buy" due to its undervalued stock, recent product launches, and resolved supply chain issues, despite underperformance over the past 7 months. The company posted solid Q2 ...

The participants were randomized either to treatment A, insulin pump Minimed 640G and independent iscCGM (Freestyle ... Author OC was employed by the company Medtronic. Author CB got speakers ...